
What we were reading this week: The search for new delivery vehicles for RNA/DNA therapeutics & vaccines heats up
Current offerings
This article covers the bottlenecks faced by mRNA vaccines such as supply chain
requirements and rapid degradation leading to limited-expression and efficacy.
This can be addressed efficiently by more stable DNA vaccines thus not requiring
cold chain handling and allowing for prolonged-expression which should improve
the efficacy and